PRTO - Proteon Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Proteon Therapeutics's activity chart (see below) currently has 4 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 100% of the time, taking 415.86 days on average.

Most recent stock forecast was given by from JMP on 28-Mar-2019. First documented stock forecast 10-May-2018.

Best performing analysts who are covering PRTO - Proteon Therapeutics:

Stephen Willey Jason Mccarthy Swayampakula Ramakanth Jason Butler

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 28-Mar-2019

$9

7 years 7 months 24 days ago
(28-Mar-2019)

1/1 (100%)

$-107 (-92.24%)

333

Hold Since 28-Mar-2019

$5

7 years 7 months 24 days ago
(28-Mar-2019)

1/1 (100%)

$-63 (-92.65%)

437

Hold Since 14-Mar-2019

$4

7 years 8 months 7 days ago
(14-Mar-2019)

1/1 (100%)

$-142.4 (-97.27%)

302

Buy Since 10-May-2018

$18

8 years 6 months 11 days ago
(10-May-2018)

1/1 (100%)

$-52 (-74.29%)

767

Show more analysts

Please expand the browser size to see the chart

What is PRTO (Proteon Therapeutics) average time for price targets to be met?

On average it took 416 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on PRTO (Proteon Therapeutics)?

Which analyst has the most public recommendations on PRTO (Proteon Therapeutics)?

has 0 price targets and 0 ratings on PRTO

Which analyst is the currently most bullish on PRTO (Proteon Therapeutics)?

Jason Mccarthy with the highest potential upside of $0

Which analyst is the currently most reserved on PRTO (Proteon Therapeutics)?

Stephen Willey with the lowest potential downside of -$23.53
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?